Peripheral Blood Mesenchymal Stem Cell–Derived Exosomes Improve Renal Sympathetic Denervation Efficacy Through β-Catenin-Mediated Cardiac Reprogramming

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objectives To explore the role of self-peripheral blood mesenchymal stem cell (PBMSC)-derived exosomes (Exos) in enhancing renal sympathetic denervation (RD)-mediated cardiac repair following myocardial infarction (MI) in a porcine model. Methods Pigs (EF < 40% post-MI) were randomized to early sham RD or RD. At 2 weeks post-MI, autologous PBMSC-Exos were collected. At 30 days post-MI, pigs received either PBMSC-Exos (2 × 10¹³ particles) or PBS and were followed until 90 days. Another cohort underwent myocardial biopsy at 14 days post-MI to assess PBMSC-Exos effects on ischemic cardiomyocyte (CM) reprogramming, followed by AAV therapy with miR-141-200-429 sponges or negative control (NC) sponges to explore the role of miR-141-200-429 clusters in reprogramming. Results Two weeks post-MI, RD hearts showed increased Exos uptake and inhibited the sympathetic nervous system. By 90 days, the RD + Exos group had 11–26% higher EF than single-treatment groups (all P < 0.001), with improved survival and reduced fibrosis. Exos therapy enhanced RD effects by inhibiting the renin-angiotensin-aldosterone system and transferring the miR-141-200-429 cluster into ischemic CMs. CMs from RD-treated hearts co-cultured with PBMSC-Exos RD exhibited a more immature state, promoting reprogramming. β-catenin overexpression further enhanced PBMSC-Exos RD effects, while miR-141-200-429 inhibition blocked RD-induced CM reprogramming and survival. Ultimately, PBMSC-Exos RD reduced Dkk1 expression and activated GSK3β phosphorylation, thereby stimulating the Wnt/β-catenin pathway. Conclusions PBMSC-Exos RD enhances RD-mediated cardiac repair by activating the Wnt/β-catenin pathway via miR-141-200-429 cluster, offering a novel therapeutic strategy for MI-induced heart failure. Our findings unveil a novel therapeutic strategy, highlighting that RD maintains its efficacy and safety when integrated with complementary approaches over extended periods.

Article activity feed